CHMP backs Merck’s Ebola vaccine, a first

EMA’s CHMP issued its first positive opinion for an Ebola vaccine and backed AbbVie’s rheumatoid arthritis treatment.

The agency recommended approving Ervebo (rVSV-ZEBOV) from Merck & Co. Inc. (NYSE:MRK), to prevent infection

Read the full 317 word article

User Sign In